Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Terumo Corporation    4543   JP3546800008

TERUMO CORPORATION

(4543)
  Report
End-of-day quote. End-of-day quote Tokyo Stock Exchange - 11/30
4147 JPY   +0.36%
11/05TERUMO CORPORATION : Press Release
CO
11/05TERUMO CORPORATION : Half-year results
CO
11/02TERUMO CORPORATION : half-yearly earnings release
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Tokyo Stock Exchange
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
4193 4216 4156 4132 4147 Last
2680700 2174100 1930200 2409800 4798300 Volume
+3.17% +0.55% -1.42% -0.58% +0.36% Change
Financials
Sales 2021 608 B 5 833 M 5 833 M
Net income 2021 70 966 M 681 M 681 M
Net Debt 2021 71 714 M 688 M 688 M
P/E ratio 2021 44,3x
Yield 2021 0,68%
Sales 2022 672 B 6 448 M 6 448 M
Net income 2022 94 052 M 902 M 902 M
Net Debt 2022 44 625 M 428 M 428 M
P/E ratio 2022 33,8x
Yield 2022 0,74%
Capitalization 3 133 B 30 026 M 30 048 M
EV / Sales 2021 5,27x
EV / Sales 2022 4,73x
Nbr of Employees 26 438
Free-Float 95,6%
More Financials
Company
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows: - cardiac surgery devices (55.7%); - medical products for hospitals (27.2%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.; - sanguine transfusion equipments... 
More about the company
Notations Surperformance© of Terumo Corporation
Trading Rating : Investor Rating :
More Ratings
All news about TERUMO CORPORATION
11/05TERUMO CORPORATION : Press Release
CO
11/05TERUMO CORPORATION : Half-year results
CO
11/02TERUMO CORPORATION : half-yearly earnings release
09/29TERUMO CORPORATION : Ex-dividend day for interim dividend
FA
09/25TERUMO : North America Brings Intelligent Enterprise to Life During Worldwide Pa..
AQ
08/06TERUMO CORPORATION : Press Release
CO
08/06TERUMO CORPORATION : 1st quarter results
CO
08/03TERUMO CORPORATION : quaterly earnings release
07/15TERUMO : Acquires Quirem Medical to Enhance Its Interventional Oncology Field
AQ
06/10TERUMO CORPORATION : Mixed general shareholder meeting
CO
05/18TERUMO CORPORATION : Slide show results
CO
05/13TERUMO CORPORATION : annual earnings release
03/30TERUMO CORPORATION : Ex-dividend day for final dividend
FA
02/06TERUMO CORPORATION : 3rd quarter results
CO
02/06TERUMO CORPORATION : Slide show Q3 results
CO
More news
News in other languages on TERUMO CORPORATION
11/02TERUMO CORPORATION : publication des résultats semestriels
11/02TERUMO CORPORATION : Veröffentlichung des Halbjahresergebnisses
08/03TERUMO CORPORATION : publication des résultats trimestriels
08/03TERUMO CORPORATION : Veröffentlichung des Quartalsergebnisses
05/13TERUMO CORPORATION : publication des résultats annuels
More news
Chart TERUMO CORPORATION
Duration : Period :
Terumo Corporation Technical Analysis Chart | 4543 | JP3546800008 | MarketScreener
Technical analysis trends TERUMO CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Average target price 4 610,77 JPY
Last Close Price 4 147,00 JPY
Spread / Highest target 30,2%
Spread / Average Target 11,2%
Spread / Lowest Target -8,37%
EPS Revisions
Managers
NameTitle
Shinjiro Sato President, CEO & Representative Director
Takayoshi Mimura Chairman
Naoki Muto Chief Financial & Accounting Officer
Hiroaki Kasukawa Chief Technology Officer & Executive Officer
Kazuhisa Senshu Chief Clinical & Regulatory Affairs Officer
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORPORATION6.74%30 026
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858